The Academy of Managed Care Pharmacy (AMCP) has launched the Biosimilars Resource Center (BRC) to provide educational resources on biosimilars to health care specialists, according to a release.1

The website will include materials aimed at pharmacists, physicians and other providers, and will include frequently asked questions, whitepapers, web-based educational seminars, continuing education programs, and journal articles.

“Biosimilars are new to the U.S. market, and many health care professionals are still unfamiliar with their potential to improve patient care and lower costs,” said AMCP CEO Susan Cantrell, RPh, CAE. “We understand that providers will have many questions about biosimilars, so we are committed to making BRC a comprehensive, 1-stop resource for unbiased, up-to-date information on these products.”

Continue Reading

While biosimilars have been available in Europe for over 10 years, they were introduced to the U.S. market only recently. They are a less expensive version of originator biological therapies that have made remarkable progress in treating debilitating diseases such as cancer and rheumatoid arthritis.

RELATED: Biosimilar to Trastuzumab Comparable in Efficacy, Safety for Advanced HER2+ Breast Cancer

“Our initiative to educate U.S. health care providers about the benefits of biosimilars will be critical in ensuring that the therapies become widely adopted and utilized in a safe and effective manner,” Cantrell said.


  1. AMCP Launches Online Biosimilars Resource Center for Pharmacists, Physicians, Other Providers [news release]. Academy of Managed Care Pharmacy. June 28, 2016. Accessed June 29, 2016.